NCT02495103 2021-01-26Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell CarcinomaNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated7 enrolled 10 charts